Catalyst Wire Dossier Catalyst Wire Dossier

pram-insulin co-formulation

pram-insulin co-formulation · Xeris Pharmaceuticals
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for pram-insulin co-formulation, covering 2024-03-27 to 2024-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D [Phase 2]

See pricing